A detailed history of Personal Capital Advisors Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Personal Capital Advisors Corp holds 12,376 shares of BSX stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,376
Previous 10,225 21.04%
Holding current value
$1.11 Million
Previous $396,000 44.44%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $85,093 - $101,570
2,151 Added 21.04%
12,376 $572,000
Q3 2022

Nov 07, 2022

BUY
$36.71 - $109.66 $83,148 - $248,379
2,265 Added 28.45%
10,225 $396,000
Q2 2022

Aug 04, 2022

BUY
$35.24 - $47.1 $1,867 - $2,496
53 Added 0.67%
7,960 $297,000
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $66,830 - $73,693
-1,634 Reduced 17.13%
7,907 $350,000
Q4 2021

Feb 11, 2022

BUY
$38.07 - $44.87 $47,397 - $55,863
1,245 Added 15.01%
9,541 $402,000
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $95,447 - $106,212
2,315 Added 38.71%
8,296 $360,000
Q2 2021

Aug 11, 2021

BUY
$38.58 - $44.24 $655 - $752
17 Added 0.29%
5,981 $256,000
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $28,180 - $31,696
-799 Reduced 11.81%
5,964 $231,000
Q4 2020

Feb 12, 2021

SELL
$33.15 - $41.97 $8,420 - $10,660
-254 Reduced 3.62%
6,763 $243,000
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $7,990 - $9,797
-232 Reduced 3.2%
7,017 $268,000
Q2 2020

Aug 12, 2020

BUY
$30.19 - $39.11 $2,988 - $3,871
99 Added 1.38%
7,249 $255,000
Q1 2020

May 12, 2020

SELL
$25.83 - $45.71 $48,276 - $85,431
-1,869 Reduced 20.72%
7,150 $233,000
Q4 2019

Feb 13, 2020

BUY
$37.87 - $45.37 $67,787 - $81,212
1,790 Added 24.76%
9,019 $408,000
Q3 2019

Nov 07, 2019

BUY
$40.31 - $43.45 $4,796 - $5,170
119 Added 1.67%
7,229 $294,000
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $11,415 - $14,054
327 Added 4.82%
7,110 $306,000
Q1 2019

May 13, 2019

BUY
$32.91 - $40.75 $296 - $366
9 Added 0.13%
6,783 $260,000
Q4 2018

Jan 16, 2019

SELL
$31.73 - $39.04 $3,363 - $4,138
-106 Reduced 1.54%
6,774 $239,000
Q3 2018

Oct 09, 2018

SELL
$32.83 - $38.63 $1,969 - $2,317
-60 Reduced 0.86%
6,880 $265,000
Q2 2018

Aug 01, 2018

SELL
$26.84 - $34.32 $65,060 - $83,191
-2,424 Reduced 25.89%
6,940 $227,000
Q1 2018

May 09, 2018

BUY
$25.2 - $28.54 $235,972 - $267,248
9,364 New
9,364 $256,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Personal Capital Advisors Corp Portfolio

Follow Personal Capital Advisors Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

News

Stay updated on Personal Capital Advisors Corp with notifications on news.